To test this hypothesis, we generated two small hairpin RNA (shRNA) vectors that expressed shRNAs that targeted mouse PCM1 and validated the efficiency of these shRNAs in knocking down PCM1 in mouse neuroblastoma (N2A) cells (Figure 5—figure supplement 1A). This evidence concerns the gene PCM1 and neuroblastoma.